<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02638285</url>
  </required_header>
  <id_info>
    <org_study_id>ShirazSUMSnew</org_study_id>
    <nct_id>NCT02638285</nct_id>
  </id_info>
  <brief_title>Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare pregnancy rate by Human Chorionic Gonadotropin (HCG) administration and urinary
      Luteinizing Hormone (LH) surge method for insemination in patients undergoing Intrauterine
      Insemination (IUI) at Montaserieh infertility center.

      The present study comprised 309 infertile women candidate for IUI, randomly divided into LH
      surge and HCG groups (assign the number for each patient, odds number for LH and even number
      for HCG group). All patients were subjected to baseline ultrasound and received clomiphene
      citrate before undergoing serial transvaginal sonography. LH was measured using LH kit when
      2-5 follicles (18-20 mm) appeared in LH surge group, and if positive, IUI was performed after
      24 hours. In HCG group, the patients received HCG 1000 units and underwent IUI after 36
      hours. The pregnancy rate was then compared in LH and HCG groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pregnancy rate</measure>
    <time_frame>Two weeks after IUI</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>HCG group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HCG group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LH group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LH group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clomiphene citrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>clomiphene citrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LH</intervention_name>
    <arm_group_label>LH group</arm_group_label>
    <arm_group_label>clomiphene citrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HCG</intervention_name>
    <arm_group_label>HCG group</arm_group_label>
    <arm_group_label>clomiphene citrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene</intervention_name>
    <arm_group_label>HCG group</arm_group_label>
    <arm_group_label>LH group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infertile women candidate for IUI

        Exclusion Criteria:

          -  women with negative urinary LH surge which required HCG administration,

          -  those with more than 5 follicles who had to use LH kit and not receive HCG to avoid
             ovarian hyperstimulation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Health Policy Research Center</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2015</study_first_submitted>
  <study_first_submitted_qc>December 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2015</study_first_posted>
  <last_update_submitted>December 18, 2015</last_update_submitted>
  <last_update_submitted_qc>December 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shiraz University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Payam Peymani</investigator_full_name>
    <investigator_title>Head Of Pharmacoepidemiology Department, Health policy Research Center,Shiraz university of Medical Sciences</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

